Pierre Flamant

Pierre Flamant is the current CFO at OncoDNA. Prior to this, they were the CFO at Ymagis Group from December 2014 to February 2017. While at Ymagis Group, Pierre organized a new finance structure and led cross-border finance teams (30 people) with 7 direct reports. Pierre also worked closely with the deputy CEO on a new 3 years strategic plan to streamline business operations and increase profitability. In addition, Pierre managed the M&A process from deal initiation to integration (5 deals for €8m value) and raised €40m funding via a bond private placement to reduce debt cost and sustain the external growth. Pierre also developed relations with existing/new investors and financial analysts (2 new coverages in 12 months) and implemented a stock-based employee incentive program.

Before Ymagis Group, Pierre was the CFO at dcinex from January 2012 to December 2014. As CFO, Pierre was a key leader of the “Be Efficient” operational excellence plan and achieved opex saving through organizational restructuring and profit/cost analysis. Pierre also reduced DSO (-20 days) by improving cash collection through new processes, tools and reporting. In addition, Pierre worked closely with the M&A director in business development strategy and achieved loan waiver requests to gain flexibility and reduce financial cost . Pierre also accompanied shareholders for expansion, consolidation and exit analysis.

Pierre Flamant has a Licentiate degree in Business & Management from Université catholique de Louvain.

Their manager is Bernard Courtieu, CEO. Pierre Flamant works with Jean-Pol Detiffe - Chief Strategy & Innovation Officer, Emmanuel Martin - COO, and Bérengère Genin - Head of Academics, Research Business Unit.